Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib 22 August 2020 | 11:10 Code : 11252 New Features Send To Others Your Name Your Email Recipient Email Send Cancel visits:18001 http://http://journal.waocp.org/article_88725.html
